Hwang Sung-Hee, Yeom Hojin, Lee Michael
Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22012, Korea.
INU Human Genome Research Center, Incheon National University, Incheon 22012, Korea.
Korean J Physiol Pharmacol. 2020 May 1;24(3):233-240. doi: 10.4196/kjpp.2020.24.3.233.
Autophagy regulators are often effective as potential cancer therapeutic agents. Here, we investigated paclitaxel sensitivity in cells with knockout (KO) of gene. The KO in multidrug resistant v-Ha--transformed NIH 3T3 cells (Ras-NIH 3T3/Mdr) was generated using the CRISPR/Cas9 technology. The qPCR and LC3 immunoblot confirmed knockout of the gene and protein of , respectively. The KO restored the sensitivity of Ras-NIH 3T3/Mdr cells to paclitaxel. Interestingly, overexpression restored autophagy function in KO cells, but failed to rescue paclitaxel resistance. These results raise the possibility that low level of resistance to paclitaxel in KO cells may be related to other roles of independent of its function in autophagy. The KO significantly induced a G/M arrest in cell cycle progression. Additionally, KO caused necrosis of a high proportion of cells after paclitaxel treatment. These data suggest that the difference in sensitivity to paclitaxel between KO and their parental MDR cells may result from the disparity in the proportions of necrotic cells in both populations. Thus, our results demonstrate that the KO in paclitaxel resistant cells leads to a marked G/M arrest and sensitizes cells to paclitaxel-induced necrosis.
自噬调节因子通常作为潜在的癌症治疗药物具有疗效。在此,我们研究了基因敲除(KO)细胞对紫杉醇的敏感性。使用CRISPR/Cas9技术在多药耐药的v-Ha-转化的NIH 3T3细胞(Ras-NIH 3T3/Mdr)中敲除该基因。qPCR和LC3免疫印迹分别证实了该基因和蛋白的敲除。该基因敲除恢复了Ras-NIH 3T3/Mdr细胞对紫杉醇的敏感性。有趣的是,该基因过表达恢复了基因敲除细胞中的自噬功能,但未能挽救紫杉醇耐药性。这些结果增加了一种可能性,即基因敲除细胞中对紫杉醇的低水平耐药性可能与其在自噬中的功能无关的其他作用有关。该基因敲除显著诱导细胞周期进程中的G/M期阻滞。此外,基因敲除导致紫杉醇处理后高比例细胞坏死。这些数据表明,基因敲除细胞与其亲本多药耐药细胞之间对紫杉醇敏感性的差异可能源于这两个群体中坏死细胞比例的差异。因此,我们的结果表明,紫杉醇耐药细胞中的该基因敲除导致明显的G/M期阻滞,并使细胞对紫杉醇诱导的坏死敏感。